These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 19926015)

  • 1. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.
    Medeiros-Domingo A; Bhuiyan ZA; Tester DJ; Hofman N; Bikker H; van Tintelen JP; Mannens MM; Wilde AA; Ackerman MJ
    J Am Coll Cardiol; 2009 Nov; 54(22):2065-74. PubMed ID: 19926015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing.
    Tester DJ; Kopplin LJ; Will ML; Ackerman MJ
    Heart Rhythm; 2005 Oct; 2(10):1099-105. PubMed ID: 16188589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing.
    Tester DJ; Arya P; Will M; Haglund CM; Farley AL; Makielski JC; Ackerman MJ
    Heart Rhythm; 2006 Jul; 3(7):800-5. PubMed ID: 16818210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases.
    Tester DJ; Spoon DB; Valdivia HH; Makielski JC; Ackerman MJ
    Mayo Clin Proc; 2004 Nov; 79(11):1380-4. PubMed ID: 15544015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of unexplained drowning: new insights from a molecular autopsy.
    Tester DJ; Kopplin LJ; Creighton W; Burke AP; Ackerman MJ
    Mayo Clin Proc; 2005 May; 80(5):596-600. PubMed ID: 15887426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes.
    Choi G; Kopplin LJ; Tester DJ; Will ML; Haglund CM; Ackerman MJ
    Circulation; 2004 Oct; 110(15):2119-24. PubMed ID: 15466642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mechanism for sudden infant death syndrome (SIDS): stress-induced leak via ryanodine receptors.
    Tester DJ; Dura M; Carturan E; Reiken S; Wronska A; Marks AR; Ackerman MJ
    Heart Rhythm; 2007 Jun; 4(6):733-9. PubMed ID: 17556193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
    Priori SG; Napolitano C; Memmi M; Colombi B; Drago F; Gasparini M; DeSimone L; Coltorti F; Bloise R; Keegan R; Cruz Filho FE; Vignati G; Benatar A; DeLogu A
    Circulation; 2002 Jul; 106(1):69-74. PubMed ID: 12093772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exon 3 deletion of ryanodine receptor causes left ventricular noncompaction, worsening catecholaminergic polymorphic ventricular tachycardia, and sudden cardiac arrest.
    Campbell MJ; Czosek RJ; Hinton RB; Miller EM
    Am J Med Genet A; 2015 Sep; 167A(9):2197-200. PubMed ID: 26018045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction.
    Ohno S; Omura M; Kawamura M; Kimura H; Itoh H; Makiyama T; Ushinohama H; Makita N; Horie M
    Europace; 2014 Nov; 16(11):1646-54. PubMed ID: 24394973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse Phenotypic Manifestations in a Family with a Novel RYR2 E4107A Variant.
    Hasegawa H; Tamura S; Nakajima T; Kawabata-Iwakawa R; Kobari T; Matsumoto N; Sano Y; Nishiyama M; Kurabayashi M; Kaneko Y; Nakatani Y; Ishii H
    Int Heart J; 2024; 65(3):580-585. PubMed ID: 38825499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
    Seidlmayer LK; Riediger F; Pagonas N; Nordbeck P; Ritter O; Sasko B
    J Med Case Rep; 2018 Oct; 12(1):298. PubMed ID: 30296944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The V2475F CPVT1 mutation yields distinct RyR2 channel populations that differ in their responses to cytosolic Ca
    Wilson AD; Hu J; Sigalas C; Venturi E; Valdivia HH; Valdivia CR; Lei M; Musgaard M; Sitsapesan R
    J Physiol; 2021 Dec; 599(23):5179-5201. PubMed ID: 34676560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.
    Sy RW; Gollob MH; Klein GJ; Yee R; Skanes AC; Gula LJ; Leong-Sit P; Gow RM; Green MS; Birnie DH; Krahn AD
    Heart Rhythm; 2011 Jun; 8(6):864-71. PubMed ID: 21315846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: findings from an international multicentre registry.
    Roston TM; Yuchi Z; Kannankeril PJ; Hathaway J; Vinocur JM; Etheridge SP; Potts JE; Maginot KR; Salerno JC; Cohen MI; Hamilton RM; Pflaumer A; Mohammed S; Kimlicka L; Kanter RJ; LaPage MJ; Collins KK; Gebauer RA; Temple JD; Batra AS; Erickson C; Miszczak-Knecht M; Kubuš P; Bar-Cohen Y; Kantoch M; Thomas VC; Hessling G; Anderson C; Young ML; Choi SHJ; Cabrera Ortega M; Lau YR; Johnsrude CL; Fournier A; Van Petegem F; Sanatani S
    Europace; 2018 Mar; 20(3):541-547. PubMed ID: 28158428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search for cardiac calcium cycling gene mutations in familial ventricular arrhythmias resembling catecholaminergic polymorphic ventricular tachycardia.
    Marjamaa A; Laitinen-Forsblom P; Lahtinen AM; Viitasalo M; Toivonen L; Kontula K; Swan H
    BMC Med Genet; 2009 Feb; 10():12. PubMed ID: 19216760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia.
    Jiang D; Jones PP; Davis DR; Gow R; Green MS; Birnie DH; Chen SR; Gollob MH
    Channels (Austin); 2010; 4(4):302-10. PubMed ID: 20676041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recurrent syncope related to catecholaminergic polymorphic ventricular tachycardia due to de novo RyR2-R2401H mutation].
    Liu X; Li JX; Hu JZ; Shen Y; Wan R; Xiong QM; Zhou QQ; Xie JY; Jin JJ; Yan X; Yu JH; Hong K
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):39-43. PubMed ID: 28100344
    [No Abstract]   [Full Text] [Related]  

  • 19. Linking the heart and the brain: Neurodevelopmental disorders in patients with catecholaminergic polymorphic ventricular tachycardia.
    Lieve KVV; Verhagen JMA; Wei J; Bos JM; van der Werf C; Rosés I Noguer F; Mancini GMS; Guo W; Wang R; van den Heuvel F; Frohn-Mulder IME; Shimizu W; Nogami A; Horigome H; Roberts JD; Leenhardt A; Crijns HJG; Blank AC; Aiba T; Wiesfeld ACP; Blom NA; Sumitomo N; Till J; Ackerman MJ; Chen SRW; van de Laar IMBH; Wilde AAM
    Heart Rhythm; 2019 Feb; 16(2):220-228. PubMed ID: 30170228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond.
    Katz G; Arad M; Eldar M
    Curr Probl Cardiol; 2009 Jan; 34(1):9-43. PubMed ID: 19068246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.